We provide you with 20 years of free, institutional-grade data for GNPX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GNPX. Explore the full financial landscape of GNPX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Genprex, Inc(NASDAQ:GNPX) 
Genprex, Inc. operates as a clinical-stage gene therapy company that develops treatments for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new treatment options for patient populations with cancer and diabetes. Its lead pro...
Website: http://www.genprex.com
Founded: 2009
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about GNPX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.